|  December 17, 2014  |  
Mostly Cloudy   32.0F  |  Forecast »
Bookmark and Share Email this page Email Print this page Print Feed Feed

FDA significantly restricts access to the diabetes drug Avandia

09-23-2010] The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.

Summary of Decision

Add your comment:
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement
Edit Module
Advertisement